Aleve-d Sinus And Cold Tablet
NDC Package 0280-6090-20
Package Information
Aleve-d Sinus And Cold (naproxen sodium, pseudeoephedrine hydrochloride) tablets is directions • do not take more than directed• the smallest effective dose should be used• swallow whole; do not crush or chew • drink a full glass of water with each dose• adults and children 12 years and older : 1 caplet every12 hours; do not take more than 2 caplets in 24 hours • children under 12 years: do not use. This formulation utilizes a tablet delivery system. Marketed by Bayer Healthcare Llc., this product is identified by NDC 0280-6090 and is authorized under FDA application ANDA076518.
Identification & Billing
- RxCUI: 1367426 - naproxen sodium 220 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Tablet
- RxCUI: 1367426 - 12 HR naproxen sodium 220 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet
- RxCUI: 1367426 - naproxen sodium 220 MG / pseudoephedrine hydrochloride 120 MG 12 HR Extended Release Oral Tablet
Clinical Specifications
- Adrenergic alpha-Agonists - [MoA] (Mechanism of Action)
- Anti-Inflammatory Agents, Non-Steroidal - [CS]
- Cyclooxygenase Inhibitors - [MoA] (Mechanism of Action)
- Nonsteroidal Anti-inflammatory Drug - [EPC] (Established Pharmacologic Class)
- alpha-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 0280 - Bayer Healthcare Llc.
- 0280-6090 - Aleve-d Sinus And Cold
- 0280-6090-20 - 2 BLISTER PACK in 1 CARTON / 10 TABLET in 1 BLISTER PACK
- 0280-6090 - Aleve-d Sinus And Cold
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0280-6090). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0280-6090-20 identifies a specific commercial package of 2 blister pack in 1 carton / 10 tablet in 1 blister pack of Aleve-d Sinus And Cold, a human over the counter drug labeled by Bayer Healthcare Llc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 2 billable units per package. This tablet is formulated for oral use and contains naproxen sodium; pseudoephedrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bayer Healthcare Llc. on January 01, 2014. The current certification is valid through December 31, 2026.
How is this Bayer Healthcare Llc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00280609020. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 2 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.